ATG4D and nasopharyngeal carcinoma: Based on our findings and the limitations identified, we propose a comprehensive roadmap for future research: 1) Larger cohort studies: Multicenter prospective studies with larger sample sizes (n > 200) are needed to validate the prognostic significance of ATG4D and other ATGs in NPC.